Cargando…

SP and KLF Transcription Factors in Cancer Metabolism

Tumor development and progression depend on reprogramming of signaling pathways that regulate cell metabolism. Alterations to various metabolic pathways such as glycolysis, oxidative phosphorylation, lipid metabolism, and hexosamine biosynthesis pathway are crucial to sustain increased redox, bioene...

Descripción completa

Detalles Bibliográficos
Autores principales: Orzechowska-Licari, Emilia J., LaComb, Joseph F., Mojumdar, Aisharja, Bialkowska, Agnieszka B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456310/
https://www.ncbi.nlm.nih.gov/pubmed/36077352
http://dx.doi.org/10.3390/ijms23179956
_version_ 1784785784695422976
author Orzechowska-Licari, Emilia J.
LaComb, Joseph F.
Mojumdar, Aisharja
Bialkowska, Agnieszka B.
author_facet Orzechowska-Licari, Emilia J.
LaComb, Joseph F.
Mojumdar, Aisharja
Bialkowska, Agnieszka B.
author_sort Orzechowska-Licari, Emilia J.
collection PubMed
description Tumor development and progression depend on reprogramming of signaling pathways that regulate cell metabolism. Alterations to various metabolic pathways such as glycolysis, oxidative phosphorylation, lipid metabolism, and hexosamine biosynthesis pathway are crucial to sustain increased redox, bioenergetic, and biosynthesis demands of a tumor cell. Transcription factors (oncogenes and tumor suppressors) play crucial roles in modulating these alterations, and their functions are tethered to major metabolic pathways under homeostatic conditions and disease initiation and advancement. Specificity proteins (SPs) and Krüppel-like factors (KLFs) are closely related transcription factors characterized by three highly conserved zinc fingers domains that interact with DNA. Studies have demonstrated that SP and KLF transcription factors are expressed in various tissues and regulate diverse processes such as proliferation, differentiation, apoptosis, inflammation, and tumorigenesis. This review highlights the role of SP and KLF transcription factors in the metabolism of various cancers and their impact on tumorigenesis. A better understanding of the role and underlying mechanisms governing the metabolic changes during tumorigenesis could provide new therapeutic opportunities for cancer treatment.
format Online
Article
Text
id pubmed-9456310
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94563102022-09-09 SP and KLF Transcription Factors in Cancer Metabolism Orzechowska-Licari, Emilia J. LaComb, Joseph F. Mojumdar, Aisharja Bialkowska, Agnieszka B. Int J Mol Sci Review Tumor development and progression depend on reprogramming of signaling pathways that regulate cell metabolism. Alterations to various metabolic pathways such as glycolysis, oxidative phosphorylation, lipid metabolism, and hexosamine biosynthesis pathway are crucial to sustain increased redox, bioenergetic, and biosynthesis demands of a tumor cell. Transcription factors (oncogenes and tumor suppressors) play crucial roles in modulating these alterations, and their functions are tethered to major metabolic pathways under homeostatic conditions and disease initiation and advancement. Specificity proteins (SPs) and Krüppel-like factors (KLFs) are closely related transcription factors characterized by three highly conserved zinc fingers domains that interact with DNA. Studies have demonstrated that SP and KLF transcription factors are expressed in various tissues and regulate diverse processes such as proliferation, differentiation, apoptosis, inflammation, and tumorigenesis. This review highlights the role of SP and KLF transcription factors in the metabolism of various cancers and their impact on tumorigenesis. A better understanding of the role and underlying mechanisms governing the metabolic changes during tumorigenesis could provide new therapeutic opportunities for cancer treatment. MDPI 2022-09-01 /pmc/articles/PMC9456310/ /pubmed/36077352 http://dx.doi.org/10.3390/ijms23179956 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Orzechowska-Licari, Emilia J.
LaComb, Joseph F.
Mojumdar, Aisharja
Bialkowska, Agnieszka B.
SP and KLF Transcription Factors in Cancer Metabolism
title SP and KLF Transcription Factors in Cancer Metabolism
title_full SP and KLF Transcription Factors in Cancer Metabolism
title_fullStr SP and KLF Transcription Factors in Cancer Metabolism
title_full_unstemmed SP and KLF Transcription Factors in Cancer Metabolism
title_short SP and KLF Transcription Factors in Cancer Metabolism
title_sort sp and klf transcription factors in cancer metabolism
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456310/
https://www.ncbi.nlm.nih.gov/pubmed/36077352
http://dx.doi.org/10.3390/ijms23179956
work_keys_str_mv AT orzechowskalicariemiliaj spandklftranscriptionfactorsincancermetabolism
AT lacombjosephf spandklftranscriptionfactorsincancermetabolism
AT mojumdaraisharja spandklftranscriptionfactorsincancermetabolism
AT bialkowskaagnieszkab spandklftranscriptionfactorsincancermetabolism